L. Juillerat-Jeanneret

Discipline

Psychologie (1) Histoire, Philosophie et Sociologie des sciences (1) Economies et finances (1)

Type de document

Articles (19) Recensions (4)

Co-auteur

Date

Source

Mot-clé

Treatment (10) Cells (10) Human beings (8) Expression (8) Animals (8) Cancer (7) tissu (corporel) (6) thérapie (6) Therapeutics (6) Inhibition (6) Properties (6) cancer (5) Development (5) Control (5) Cancer (5) Inhibitors (5) Diseases (5) Diseases (5) stress (4) évaluation (4) maladie (4) Growth (4) Functions (4) Evaluation (4) Use (4) Synthesis (4) Growth (4) Evaluation (4) maladie (4) administration (3)

Documents écrit par L. Juillerat-Jeanneret (19) | parle de L. Juillerat-Jeanneret (0)

Differential Effects of the Mitochondria-Active Tetrapeptide SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH2) and Its Peptidase-Targeted Prodrugs in Experimental Acute Kidney Injury.
J.C. Wyss et al. (2019)
Fibrogenic Disorders in Human Diseases: From Inflammation to Organ Dysfunction.
L. Juillerat-Jeanneret et al. (21 nov. 2018)
Targeted γ-secretase inhibition of Notch signaling activation in acute renal injury.
J.C. Wyss et al. (1 mai 2018)
Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?
L. Juillerat-Jeanneret et al.
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.
R. Kumar et al. (8 sept. 2016)
Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis.
J.D. Aubert et al. (2016)
Differential stress reaction of human colon cells to oleic-acid-stabilized and unstabilized ultrasmall iron oxide nanoparticles.
C.A. Schütz et al. (2014)
Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
L. Juillerat-Jeanneret (2014)
Stress reaction of kidney epithelial cells to inorganic solid-core nanoparticles.
B. Halamoda Kenzaoui et al.
Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells.
B.H. Kenzaoui et al. (2012)
Expression of dual angiogenic/neurogenic growth factors in human primary brain tumors.
M. Clemessy et al. (2012)
Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells.
D. Staedler et al. (2011)
Sawhorse-type diruthenium tetracarbonyl complexes containing porphyrin-derived ligands as highly selective photosensitizers for female reproductive cancer cells.
F. Schmitt et al. (2009)
Combined arene ruthenium porphyrins as chemotherapeutics and photosensitizers for cancer therapy.
F. Schmitt et al.
The contractile properties of vaginal myofibroblasts: is the myofibroblasts contraction force test a valuable indication of future prolapse development?
S. Meyer et al. (2008)
Evaluation of the interaction between TGF beta and nitric oxide in the mechanisms of progression of colon carcinoma
S. Lohm et al. (2005)
Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma.
L. Juillerat-Jeanneret et al. (8 mars 2004)
Tumour-derived and host-derived nitric oxide differentially regulate breast carcinoma metastasis to the lungs
N. Gauthier et al. (2004)
Endothelin-receptor antagonists are proapoptotic and antiproliferative in human colon cancer cells.
L. Peduto Eberl et al. (10 mars 2003)